{"version":"1.0","type":"link","title":"Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma.","author_name":"Zhuang H 외","author_url":"https://prs-insight.online/author/Zhuang%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/115806","thumbnail_width":1200,"thumbnail_height":630}